Takeda Pharmaceutical TAK
NYSE TAK
$18.15 -0.19 (-1.06%)
At close: Aug 20, 2026 · 3:06 PM UTC

Takeda Pharmaceutical (TAK) EPS (Diluted) Growth (1y) (2018 - 2026)

Takeda Pharmaceutical (TAK) EPS (Diluted) Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (1y) (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn -304.28%
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn 1.28%
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn -15.70%
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn 13.47%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -2,504.14%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 30.20%
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn 385.28%
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Alkermes 8.09 Bn 7.44 Bn 397.90 Mn -99.42%

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.70%
Mar 31, 2026 -0.85%
Dec 31, 2025 -253.48%
Sep 30, 2025 3.85%
Jun 30, 2025 38.15%
Mar 31, 2025 24.75%
Dec 31, 2024 -419.78%
Sep 30, 2024 -29.67%
Jun 30, 2024 -7.11%
Mar 31, 2024 -19.61%
Dec 31, 2023 -75.28%
Sep 30, 2023 340.14%
Jun 30, 2023 -20.22%
Mar 31, 2023 915.98%
Dec 31, 2022 66.68%
Sep 30, 2022 8.21%
Jun 30, 2022 -34.61%
Mar 31, 2022 -105.24%
Dec 31, 2021 -42.57%
Sep 30, 2021 993.11%